Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precision Global is a premier global manufacturer of aerosol valves, actuators, and dispensing solutions, with a significant presence in the pharmaceutical and healthcare industries. The company is best known for its expertise in metered-dose inhaler (MDI) technology, providing critical components for the delivery of respiratory medications for conditions such as asthma and COPD. Founded in 1949 by Robert Abplanalp, the inventor of the modern aerosol valve, Precision Global operates a vast international manufacturing network across multiple continents. The company serves as a key Contract Manufacturing Organization (CMO) and component supplier to major global pharmaceutical firms, ensuring precise dosage and delivery of medications. Currently owned by the private equity firm ONCAP, Precision Global continues to innovate in precision dispensing and drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precision Global.